Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | BTM-3566 |
| Synonyms | |
| Therapy Description |
BTM-3566 is a small molecule that activates mitochondrial OMA1 and the integrated stress response, which potentially results in increased apoptosis in tumor cells and decreased tumor growth (PMID: 37643767). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| BTM-3566 | BTM3566|BTM 3566 | BTM-3566 is a small molecule that activates mitochondrial OMA1 and the integrated stress response, which potentially results in increased apoptosis in tumor cells and decreased tumor growth (PMID: 37643767). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06792734 | Phase I | BTM-3566 | Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas | Recruiting | USA | 0 |